Loading clinical trials...
Loading clinical trials...
Cancer patients have a well-known and higher risk of vaccine-preventable disease (VPD) than the general population. VPD can cause serious complications due to compromised immune system, malnutrition and the same oncology treatments and represent a severe financial burden with a delay in treating the underlying cancer The main purpose of this survey is to analyse the perception of cancer patients on the topic vaccines and vaccine-preventable diseases, the acceptability of vaccines and the evaluation of the determining factors associated with the choice of the patient to be vaccinated or not. This information will be used to improve the management of these issues.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Fondazione IRCCS Policlinico San Matteo, SC Oncologia
Pavia, Pavia, Italy
Start Date
May 31, 2024
Primary Completion Date
August 26, 2024
Completion Date
August 26, 2024
Last Updated
March 17, 2025
309
ACTUAL participants
Lead Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
NCT07103018
NCT06860425
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions